New blood test spots silent liver metastases in pancreatic cancer patients
NCT ID NCT07224802
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new blood test that looks for tiny particles (exosomes) released by cancer cells to find early liver spread in people with pancreatic cancer before they have surgery. The goal is to help doctors decide the best treatment plan by identifying patients at high risk of hidden liver metastases. The study involved 372 participants and used machine learning to analyze the blood samples.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common diabetes drug boost chemotherapy against pancreatic cancer?
- New laser blood test could spot pancreatic cancer early
- New hope for hard-to-treat pancreatic cancer: targeted drug combo enters phase 3 trial
- Blood test hunt for silent killer: 5,000 High-Risk volunteers sought
- Supercharged t cells take on Hard-to-Treat cancers
- Massive cancer registry aims to unlock better GI cancer care